The new European Paediatric Translational Research Infrastructure (EPTRI) has been presented at the 16th meeting of the European Society for Developmental Perinatal and Pediatric Pharmacology (ESDPPP) Congress, held in Belgium on 20-23 June 2017, in the section “New tools and approaches to further improve paediatric pharmacotherapy and studies “.

ESDPPP is a non-profit association that puts together pharmacologists, clinicians, and scientists to promote research in developmental perinatal and paediatric pharmacology around the world.

The 16th ESDPPP congress has been the occasion to highlight the urgent need to have a Research Infrastructure (RI) dedicated to Paediatrics to cover the gap in scientific research and new technologies affecting the field of paediatric medicinal products.

The EPTRI proposal, coordinated by CVBF-TEDDY and submitted on March 29th, 2017, within the INFRADEV-01-2017 single-stage call for proposals, will represent a complementary RI in the context of the existing RIs to cover the current gaps in paediatric medicines and to enhance technology-driven paediatric research in discovery and early development phases. EPTRI will be a network of different research groups focused on specific research themes (specialised Platforms), an open science space allowing researchers to work together without geographical, institutional or financial barriers and a “one-stop-shop” for advice in paediatric drug development research.

The project can count on a noteworthy partnership, made up of 26 partners from 19 EU/Associated countries.
The evaluation of the project proposals is expected within 5 months from the submission (August 2017). Let’s keep our fingers crossed!

You can find the abstract submitted to the congress here.
More information about EPTRI are available here.